October 20, 2020
University of Cincinnati epidemiologist Diego Cuadros is used to telling people what they don’t want to hear. The assistant professor runs the Health Geography and Disease Modeling Lab in UC’s College of Arts and Sciences, where he studies global topics such as HIV, malaria and, this year, COVID-19. He condenses data into easy-to-follow maps that predict the future with uncanny accuracy.
October 20, 2020
Carl Fichtenbaum, a professor in the Division of Infectious Diseases at the University of Cincinnati College of Medicine and one of the leaders in UC’s efforts to combat COVID-19, is still going to protest marches as his passion for social justice, personally and profession- ally, burns as brightly as ever.
October 16, 2020
Event: November 4, 2020 9:00 AM
The University of Cincinnati’s first Healthcare Workforce Diversity Symposium features a series of live and recorded talks on November 4, 2020.
October 15, 2020
Four University of Cincinnati students have joined the inaugural class of interns participating in Cincinnati Public Radio’s Democracy & Me program.
October 13, 2020
Event: October 17, 2020 9:30 AM
The UC Center for Integrative Health and Wellness and the UC Cancer Center’s Survivorship and Supportive Services Programs are presenting the event specifically for cancer survivors.
October 12, 2020
In one of the first studies of its kind, a University of Cincinnati researcher is using a grant from the Ohio attorney general’s office to research the pharmacogenomics of opioid addiction. The grant was awarded to Caroline Freiermuth, MD, associate professor in the Department of Emergency Medicine at the UC College of Medicine, the principal investigator for the study. The initial year will be supported with $1.63 million from the attorney general’s office, secured through money collected from pharmaceutical companies involved in opioid lawsuits.
October 12, 2020
In one of the first studies of its kind, a University of Cincinnati researcher is using a grant from the Ohio attorney general’s office to research the pharmacogenomics of opioid addiction. The grant was awarded to Caroline Freiermuth, MD, associate professor in the Department of Emergency Medicine at the UC College of Medicine, the principal investigator for the study. The initial year will be supported with $1.63 million from the attorney general’s office, secured through money collected from pharmaceutical companies involved in opioid lawsuits. Pharmacogenomics, a relatively new field, is the study of how genes affect a person's response to drugs.
October 6, 2020
The University of Cincinnati will study the economics of deploying autonomous drones to perform a variety of important tasks for Ohio’s Department of Transportation.
October 2, 2020
A research center devoted to the science of addiction and determined to make a national impact has launched at the University of Cincinnati College of Medicine.
October 1, 2020
The University of Cincinnati’s School of Planning is stepping up to remind us that cities aren’t the source of America’s current predicaments, but instead can be the ultimate solution to a healthier, more sustainable, and more equitable society.
October 1, 2020
The UC College of Medicine has established the Center for Addiction Research to expand the university’s scope as a national leader in addiction science.
September 29, 2020
UC College of Law Professor Ronna Greff Schneider discusses the complex issue of students' rights versus school rules.
September 23, 2020
With additional funding from a Seasongood grant, the UC journalism department puts focus on urban and political reporting.
September 22, 2020
Event: October 2, 2020 5:00 PM
The University of Cincinnati’s Classics Department is co-sponsoring a free virtual Zoom production on Oct. 2 of “Antigone in Ferguson” by the acclaimed Theater of War, which presents readings of classical Greek tragedies followed by a public discussion about how the themes from the ancient texts are relevant today.
September 17, 2020
Early in the onset of the COVID-19 pandemic, a small study in China produced results that influenced subsequent research on the virus. Researchers at the University of Cincinnati used the same study parameters on a much larger patient population and reached completely different findings. The study was published in the journal Progress in Cardiovascular Diseases in mid-July.